Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • CleanTech • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science • Oncology • Pharmaceutical (& Medicine) |
Stages | Seed, Series A, Series B |
Investing | United States |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Assets Under Management | $163,600,000 |
Domain Associates is a prominent venture capital firm founded in 1985 and headquartered in Princeton, New Jersey. With an expertise in equity investments, Domain focuses primarily on innovative healthcare and life sciences sectors. They invest in companies that are developing advances in therapeutics, medical devices, clinical diagnostics, healthcare services, and pharmaceuticals, offering crucial support to firms across various stages of growth, including Seed, Series A, and Series B financing rounds. With a substantial $163.6 million in assets under management, Domain Associates positions itself as a significant player in the venture capital landscape. The firm's investment range typically extends from $100,000 to a maximum of $5,000,000, with a 'sweet spot' investment size of around $1,500,000. As pioneers in the field, Domain claims to be the investment advisors to the first VC fund dedicated to biotech, managing a total of nine subsequent biotech VC funds. Their portfolio showcases the funding of 194 biopharmaceutical, device, and diagnostic companies leading to 90 IPOs and 110 M&A events, which form an impressive market capitalization of the funded companies totaling approximately $190 billion. Domain Associates' team members, composed of partners and venture partners, demonstrate a wealth of experience and are instrumental in driving the success of their investment operations, continuing a legacy that has helped define and grow the biotech venture funding environment. The team's breadth of knowledge and experience underscores their commitment to fostering innovation within the sectors they invest in.